Skip to main content
Fig. 6 | BMC Gastroenterology

Fig. 6

From: Comparative efficacy and safety of infliximab and vedolizumab therapy in patients with inflammatory bowel disease: a systematic review and meta-analysis

Fig. 6

Forest plots showing the proportion of patients with ulcerative colitis achieving clinical remission during A the induction phase and B the maintenance phase with infliximab (upper plot) or vedolizumab (lower plot). Panel A Abbreviation: CI, confidence interval. Panel B CT-P13 SC trial (a): CT-P13 SC only; CT-P13 SC trial (b): CT-P13 IV switch to CT-P13 SC; VISIBLE 1 (a): VDZ SC; VISIBLE 1 (b): VDZ IV Abbreviation: CI, confidence interval; IV, intravenous; SC, subcutaneous

Back to article page

BMC Gastroenterology

ISSN: 1471-230X

Contact us